Clinical Characteristics And Comorbid Factors In Patients In Supervision (PDP) Coronavirus Disease 2019 (Covid-19) At Mitra Medika Amplas Hospital

by ADMIN 147 views

Introduction

Understanding the Clinical Features of Covid-19

Coronavirus Disease 2019 (Covid-19) is an infectious disease caused by the SARS-COV-2 virus, which has spread rapidly throughout the world since its inception. According to the World Health Organization (WHO) data as of November 22, 2020, there were more than 57 million confirmed cases and over 1.3 million deaths due to COVID-19 globally. In Indonesia alone, there have been more than 497 thousand confirmed cases, 15,884 deaths, and over 64,502 cases of PDP (patients under supervision). The clinical symptoms of Covid-19 can range from mild symptoms such as coughs, fever, and fatigue to severe symptoms such as shortness of breath, pneumonia, and organ failure.

The Importance of Comorbid Factors in Covid-19

The comorbid factor, or the accompanying disease that a patient has, can increase the risk of complications and deaths due to COVID-19. This study aims to understand the clinical characteristics and comorbid factors found in PDP Covid-19 patients treated at Mitra Medika Amplas Hospital, Medan, North Sumatra.

Method

Retrospective Study Design

This study uses a descriptive design with retrospective data. Data was collected from the medical records of 110 PDP Covid-19 patients treated at Mitra Medika Amplas Hospital. Inclusion and exclusion criteria were applied to ensure data accuracy.

Results

Clinical Symptoms and Comorbid Factors

The results showed that the most common clinical symptoms found in PDP Covid-19 patients in Mitra Medika Amplas Hospital were coughing (82.7%), fever (64.5%), and shortness of breath (60%). The most common comorbid factors found were diabetes mellitus (DM) (20%) and hypertension (16.4%).

Conclusion

Clinical Characteristics and Comorbid Factors

Cough is a clinical symptom that is most often found in PDP Covid-19 patients at Mitra Medika Amplas Hospital. PDP Covid-19 patients with DM and hypertension have a higher risk of experiencing complications and deaths from COVID-19.

Additional Analysis and Explanation

Understanding the Clinical Features of Covid-19

The results of this study are in line with several previous studies that show that coughing, fever, and shortness of breath are common symptoms in COVID-19 patients. It is essential to note that the clinical symptoms of Covid-19 can vary from person to person. Some patients may experience mild symptoms, while others may experience severe symptoms.

The Importance of Comorbid Factors in Covid-19

Diabetes mellitus and hypertension are the main risk factors for COVID-19 complications. Patients with DM have a weak immune system, which makes them more susceptible to infection. Hypertension can cause damage to blood vessels, which can increase the risk of blood clots and stroke.

Recommendation

Identifying and Monitoring PDP Covid-19 Patients

This study shows the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension. Patients with this comorbid factor require special attention and must be closely monitored to prevent complications.

Conclusion

Increasing Alertness and Preventive Measures

Increasing alertness and preventive measures for COVID-19 is very important, especially for vulnerable groups such as patients with DM and hypertension. Routine examination and blood sugar control and blood pressure are very important to reduce the risk of complications and deaths from Covid-19.

Clinical Characteristics and Comorbid Factors in PDP Covid-19 Patients

Clinical Features of Covid-19

  • Coughing (82.7%)
  • Fever (64.5%)
  • Shortness of breath (60%)

Comorbid Factors

  • Diabetes mellitus (DM) (20%)
  • Hypertension (16.4%)

Risk Factors for COVID-19 Complications

  • Diabetes mellitus (DM)
  • Hypertension

Importance of Identifying and Monitoring PDP Covid-19 Patients

  • Patients with DM and hypertension require special attention and close monitoring to prevent complications.
  • Routine examination and blood sugar control and blood pressure are essential to reduce the risk of complications and deaths from Covid-19.

Limitations of the Study

  • The study used retrospective data, which may have limitations in terms of accuracy and completeness.
  • The study was conducted at a single hospital, which may limit the generalizability of the results.

Future Directions

  • Further studies are needed to confirm the findings of this study and to identify other risk factors for COVID-19 complications.
  • Public health campaigns and education programs should be implemented to raise awareness about the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension.

Q: What is the main objective of this study?

A: The main objective of this study is to understand the clinical characteristics and comorbid factors found in PDP Covid-19 patients treated at Mitra Medika Amplas Hospital, Medan, North Sumatra.

Q: What are the most common clinical symptoms found in PDP Covid-19 patients?

A: The most common clinical symptoms found in PDP Covid-19 patients in Mitra Medika Amplas Hospital were coughing (82.7%), fever (64.5%), and shortness of breath (60%).

Q: What are the most common comorbid factors found in PDP Covid-19 patients?

A: The most common comorbid factors found in PDP Covid-19 patients in Mitra Medika Amplas Hospital were diabetes mellitus (DM) (20%) and hypertension (16.4%).

Q: Why are diabetes mellitus and hypertension considered risk factors for COVID-19 complications?

A: Diabetes mellitus and hypertension are considered risk factors for COVID-19 complications because patients with DM have a weak immune system, which makes them more susceptible to infection. Hypertension can cause damage to blood vessels, which can increase the risk of blood clots and stroke.

Q: What is the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension?

A: Patients with DM and hypertension require special attention and must be closely monitored to prevent complications. Routine examination and blood sugar control and blood pressure are essential to reduce the risk of complications and deaths from Covid-19.

Q: What are the limitations of this study?

A: The study used retrospective data, which may have limitations in terms of accuracy and completeness. The study was conducted at a single hospital, which may limit the generalizability of the results.

Q: What are the future directions for this study?

A: Further studies are needed to confirm the findings of this study and to identify other risk factors for COVID-19 complications. Public health campaigns and education programs should be implemented to raise awareness about the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension.

Q: What can be done to reduce the risk of complications and deaths from Covid-19 in PDP patients?

A: Routine examination and blood sugar control and blood pressure are essential to reduce the risk of complications and deaths from Covid-19. Public health campaigns and education programs should be implemented to raise awareness about the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension.

Q: How can healthcare providers identify and monitor PDP Covid-19 patients with comorbid factors such as DM and hypertension?

A: Healthcare providers can identify and monitor PDP Covid-19 patients with comorbid factors such as DM and hypertension by conducting regular check-ups, monitoring blood sugar levels and blood pressure, and providing education and support to patients and their families.

Q: What is the role of public health campaigns and education programs in reducing the risk of complications and deaths from Covid-19?

A: Public health campaigns and education programs play a crucial role in reducing the risk of complications and deaths from Covid-19 by raising awareness about the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension.

Additional FAQs

Q: What is the definition of PDP Covid-19 patients?

A: PDP Covid-19 patients are patients who are under supervision due to Covid-19 infection.

Q: What is the significance of this study?

A: This study is significant because it provides valuable information about the clinical characteristics and comorbid factors found in PDP Covid-19 patients, which can inform public health policies and practices.

Q: What are the implications of this study for public health?

A: The implications of this study for public health are that it highlights the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension to reduce the risk of complications and deaths from Covid-19.

Conclusion

This FAQ article provides answers to frequently asked questions about clinical characteristics and comorbid factors in PDP Covid-19 patients. The study highlights the importance of identifying and monitoring PDP Covid-19 patients with comorbid factors such as DM and hypertension to reduce the risk of complications and deaths from Covid-19.